SEI Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-44,302
Closed -$1.6M – 2719
2023
Q2
$1.6M Sell
44,302
-5,912
-12% -$244K ﹤0.01% 1715
2023
Q1
$1.87M Buy
+50,214
New +$2.26M ﹤0.01% 1650
2022
Q4
– Sell
-54,669
Closed -$3.82M – 2713
2022
Q3
$3.82M Buy
54,669
+874
+2% +$64.7K 0.01% 1219
2022
Q2
$3.61M Buy
53,795
+48,496
+915% +$3.08M 0.01% 1258
2022
Q1
$436K Sell
5,299
-50
-0.9% -$5.11K ﹤0.01% 2146
2021
Q4
$785K Buy
5,349
+12
+0.2% +$1.86K ﹤0.01% 1939
2021
Q3
$944K Sell
5,337
-2,049
-28% -$330K ﹤0.01% 1804
2021
Q2
$1.19M Sell
7,386
-4,520
-38% -$726K ﹤0.01% 1741
2021
Q1
$2.28M Buy
11,906
+2,596
+28% +$514K 0.01% 1392
2020
Q4
$2.04M Sell
9,310
-5,462
-37% -$1.18M 0.01% 1378
2020
Q3
$2.45M Buy
14,772
+5,491
+59% +$751K 0.01% 1195
2020
Q2
$1.06M Sell
9,281
-860
-8% -$83.4K ﹤0.01% 1539
2020
Q1
$780K Sell
10,141
-822
-7% -$73.7K ﹤0.01% 1570
2019
Q4
$1.41M Buy
10,963
+4
+0% +$386 ﹤0.01% 1491
2019
Q3
$854K Sell
10,959
-1,236
-10% -$116K ﹤0.01% 1668
2019
Q2
$1.26M Sell
12,195
-8,369
-41% -$652K ﹤0.01% 1524
2019
Q1
$1.51M Buy
+20,564
New +$1.4M 0.01% 1423
2018
Q3
– Sell
-20,154
Closed -$994K – 3552
2018
Q2
$994K Buy
+20,154
New +$761K ﹤0.01% 1589

Other funds holding MRTX

SEI Investments's MRTX Position: Q3 2023 in Review

SEI Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 44,302 shares — an estimated $1.6M sold.

SEI Investments first reported a position in MRTX in Q2 2018 and held it in 18 quarters. The position peaked at $3.82M in Q3 2022. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.

  • SEI Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • SEI Investments sold 44,302 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.6M.
  • SEI Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • SEI Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $3.82M in Q3 2022.
  • 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.

Based on SEI Investments's 13F filing for Q3 2023, filed 14 Nov 2023.